Form4insider filings, from the source

Insider holders · CIK 0001382911

Orexigen Therapeutics, Inc. · OREXQ

Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity

InsiderDirect sharesIndirect sharesTotal reportedLast report (ET)From
SAK CORP10% Owner—22,268,39922,268,399Mar 24, 2016 · 5:18 pm EDTForm 3
Preston KlassenEVP, Global Development10,160—10,160Feb 4, 2016 · 12:06 pm ESTForm 4
Michael NarachiCEO & President8,356—8,356Jun 2, 2017 · 4:55 pm EDTForm 4
Thomas R CannellEVP, COO, Pres Global Com Prod3,882—3,882Jun 2, 2017 · 4:33 pm EDTForm 4
Mark D BoothChief Commercial Officer3,810—3,810Mar 2, 2015 · 5:34 pm ESTForm 4
Jason A KeyesSVP, Chief Financial Officer3,031—3,031Jun 2, 2017 · 4:44 pm EDTForm 4
Thomas P. LynchEVP. General Counsel & Sec.1,704—1,704Jun 2, 2017 · 4:47 pm EDTForm 4
Peter D FlynnSVP, Dev, Reg Affairs, Safety1,236—1,236Jul 14, 2016 · 2:29 pm EDTForm 3
Baupost Group GP, L.L.C.10% Owner—00Oct 31, 2018 · 4:04 pm EDTForm 4
Stephen A. MogliaVP & Chief Accounting Officer0—0Mar 16, 2018 · 4:20 pm EDTForm 4
Heather S AceEVP, Global Human Resources0—0Feb 4, 2016 · 11:58 am ESTForm 3
BAUPOST GROUP LLC/MA10% Owner—00Oct 31, 2018 · 4:04 pm EDTForm 4
Seth A Klarman10% Owner—00Oct 31, 2018 · 4:04 pm EDTForm 4

Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.